About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

28.10 -1.68 (-5.64%)

Streaming Delayed Price Updated: 3:47 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mineralys Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 12, 2025

Via Benzinga

Keep an eye on the top gainers and losers in Monday's session. ↗

March 10, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Monday's session: top gainers and losers ↗

March 10, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate ↗

March 10, 2025

Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood pressure reductions and a strong safety profile.

Via Benzinga

Earnings Scheduled For February 12, 2025 ↗

February 12, 2025

Via Benzinga

Insights into Mineralys Therapeutics's Upcoming Earnings ↗

November 08, 2024

Via Benzinga

Mineralys Therapeutics Earnings Preview ↗

March 20, 2024

Via Benzinga

Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher ↗

March 10, 2025

Via Benzinga

Topics Stocks

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 10, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday ↗

March 10, 2025

Via Benzinga

Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket ↗

March 10, 2025

Via Benzinga

Which stocks are moving after the closing bell on Friday? ↗

March 07, 2025

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

February 06, 2025

Via Benzinga

Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

January 29, 2025

Via Benzinga

Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 24, 2025

Via Benzinga

Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗

January 24, 2025

Via Benzinga

Earnings Scheduled For November 11, 2024 ↗

November 11, 2024

Via Benzinga

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!

September 12, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

September 09, 2024

From Schall Law

Via GlobeNewswire

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024 ↗

August 13, 2024

MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024 ↗

May 09, 2024

MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023 ↗

March 21, 2024

MLYS stock results show that Mineralys Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday ↗

February 08, 2024

U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday.

Via Benzinga

Topics Stocks

Earnings Scheduled For March 21, 2024 ↗

March 21, 2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 08, 2024

Via Benzinga

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 08, 2024

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Via Benzinga

Praxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy

September 19, 2023

From Praxis Bioresearch, Inc.

Via GlobeNewswire

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying ↗

September 11, 2023

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

All News about Mineralys Therapeutics, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us